SCHEMBL3965944

SCHEMBL3965944

COS(=O)(=O)[O-].C[N+](C)(C)CCOc1ccccc1N

nearest known ligand 0.47

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 1/20 0.38
CHRM3 known ✓ P20309 1/20 0.38
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
ALDH1A1 P00352 4/20 0.44
ADRA2B P18089 1/20 0.40
PTGS1 P23219 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CHRM2 P08172 1/20 0.38
LMNA P02545 2/20 0.37
RECQL P46063 1/20 0.37
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36
CHRNA10 Q9GZZ6 1/20 0.36
CHRNA9 Q9UGM1 1/20 0.36
POLB P06746 1/20 0.36
TERT O14746 1/20 0.35
CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12844852 0.86 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B
SCHEMBL3967819 0.80 RAB9A (0.59) CYP2C19ALDH1A1TDP1LMNARECQL
Bromide SCHEMBL2073135 0.77 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B
SCHEMBL3973363 0.75 LMNA (0.40) CYP2C19ALDH1A1LMNACHRNA7POLB
SCHEMBL3968319 0.74 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B
SCHEMBL3966313 0.73 POLB (0.35) ALDH1A1CHRM2CHRM1CHRM3POLB
SCHEMBL15016415 0.73 MAPT (0.40) ALDH1A1TDP1LMNARECQLMEN1
SCHEMBL3969300 0.72 CTDSP1 (0.45) CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B
SCHEMBL9294258 0.71 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B
SCHEMBL17197393 0.70 CYP1A2 (0.62) CYP1A2CYP2C9CYP2C19ALDH1A1ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937289-A4 COMPOSITIONS AND METHODS COMPRISING PANAX SPECIES HERBALSCIENCE SINGAPORE PTE LTD (US) 2009-07-29 EP claimed
EP-1937289-A2 COMPOSITIONS AND METHODS COMPRISING PANAX SPECIES Herbalscience Singapore Pte. Ltd. (US) 2008-07-02 EP claimed
WO-2007035723-A2 COMPOSITIONS AND METHODS COMPRISING PANAX SPECIES HERBALSCIENCE SINGAPORE PTE. LTD. (US) 2007-03-29 WO claimed
US-7517367-B2 Cationic naphthyldiazo dyes and keratin fibers-coloring agents containing these dyes WELLA AG (DE) 2009-04-14 US disclosed
US-20080167453-A1 Cationic Naphthyldiazo Dyes and Keratin Fibers-Coloring Agents Containing These Dyes WELLA AG (DE) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167453-A1 Cationic Naphthyldiazo Dyes and Keratin Fibers-Coloring Agents Containing These Dyes KRT18, KPNB1, KPNA3 CHRM1 3277/4885CHRM3 3413/4885CYP1A2 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.